Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GMED | A | Globus Medical, Inc. | 1.58 | |
TGTX | B | TG Therapeutics, Inc. | 10.91 | |
AXSM | B | Axsome Therapeutics, Inc. | 3.79 | |
AUPH | B | Aurinia Pharmaceuticals Inc | 6.43 | |
IFRX | B | InflaRx N.V. | 0.98 | |
GH | B | Guardant Health, Inc. | 0.98 | |
MNOV | B | MediciNova, Inc. | 2.56 | |
DCTH | B | Delcath Systems, Inc. | 2.28 | |
PULM | B | Pulmatrix, Inc. | 8.72 | |
KRYS | C | Krystal Biotech, Inc. | 2.35 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Biopharmaceutical
Biotechnology
Cancer
Clinical Medicine
Immunology
Monoclonal Antibodies
Antibody Drug Conjugate
Autoimmune Disease
Biology
Breast Cancer
Cancer Treatment
Clinical Research
Colitis
Immunotherapy
Life Sciences
Ovarian Cancer
Solid Tumors
Treatment Of Breast Cancer
Ulcer
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EKG | B | First Trust Nasdaq Lux Digital Health Solutions ETF | 6.03 | |
HELX | D | Franklin Genomic Advancements ETF | 5.64 | |
SHLD | B | Global X Defense Tech ETF | 4.86 | |
TMFS | A | Motley Fool Small-Cap Growth ETF | 4.73 | |
HACK | B | ETFMG Prime Cyber Security ETF | 4.51 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Cancer
Medicine
Pain
Biotechnology
Disease
Drug Development
Gene Therapy
Metabolic Disease
Oncology
Sarcoma
Technology Products
Treatment Of Cancer
Acute Intermittent Porphyria
Acute Pain
Adeno Associated Virus
Alcohol
Alipogene Tiparvovec
Aminoglycoside
Anti Infectives
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles